Lucinda Stebbins - Tekla Life Independent Trustee
| XHQLX Fund | USD 15.37 0.18 1.18% |
Ms. Lucinda H. Stebbins, CPA is Independent Trustee of HQ Life Sciences Investors. Ms. Stebbins brings to each Fund over twenty years experience working in the fund industry, providing valuable perspectives on a variety of technical and industry matters. She serves as Chairman of the Audit Committee and serves on the Governance and Nominating Committee of each Fund. She started her career with the investment management firm of Scudder, Stevens and Clark, which was later merged into the U.S. operations of Zurich Financial Services, and then finally acquired by Deutsche Bank. She served as a Senior Vice President at Scudder Investments and subsequently as a Director at Deutsche Asset Management and was an officer of approximately 200 funds in these complexes
| Age | 71 |
| Tenure | 18 years |
| Professional Marks | CPA |
Lucinda Stebbins Latest Insider Activity
Tracking and analyzing the buying and selling activities of Lucinda Stebbins against Tekla Life mutual fund is an integral part of due diligence when investing in Tekla Life. Lucinda Stebbins insider activity provides valuable insight into whether Tekla Life is net buyers or sellers over its current business cycle. Note, Tekla Life insiders must abide by specific rules, including filing SEC forms every time they buy or sell Tekla Life'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Lucinda Stebbins over a month ago Insider Trading |
Similar Money Managers
| Found 10 records | One Year Return | ||
| Michael Perre | Vanguard Total International | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Michael Perre | Vanguard Total International | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Michelle Louie | Vanguard 500 Index | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
| Gerard OReilly | Vanguard Total Stock | N/A | |
Tekla Life Sciences Leadership Team
Elected by the shareholders, the Tekla Life's board of directors comprises two types of representatives: Tekla Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Life's management team and ensure that shareholders' interests are well served. Tekla Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Reardon, Independent Trustee | ||
| Michael Bonney, Independent Trustee | ||
| Oleg Pohotsky, Independent Trustee | ||
| Lucinda Stebbins, Independent Trustee | ||
| Daniel Omstead, President Trustee | ||
| Uwe Reinhardt, Independent Trustee | ||
| Rakesh Jain, Independent Trustee |
Tekla Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right mutual fund is not an easy task. Is Tekla Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tekla Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tekla Life's short interest history, or implied volatility extrapolated from Tekla Life options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.